Screening for identified and unidentified protein C pathway defects by the Agkistrodon contortrix venom test in consecutive patients

American Journal of Clinical Pathology

Volumn 112, Issue 2, 1999, Pages 233-237

  Robert, Annie ^a   Aillaud, Marie Françoise ^b   Eschwège, Valérie ^b   Verdy, Elizabeth ^b   Barthet, Marie Christine ^b   Morange, Pierre E ^b   Juhan Vague, Irène ^b  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b NONE

Author keywords

Agkistrodon contortrix venom (ACV) test; Protac; Protein C pathway; Venous thrombosis

Indexed keywords

BLOOD CLOTTING FACTOR 8; PROTEIN C; SNAKE VENOM;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; FAMILY STUDY; FEMALE; HEMATOLOGICAL PARAMETERS; HUMAN; MAJOR CLINICAL STUDY; MALE; PARTIAL THROMBOPLASTIN TIME; POINT MUTATION; PRIORITY JOURNAL; RISK FACTOR; SCREENING TEST; THROMBOSIS; VEIN THROMBOSIS;

EID: 0033490451     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/112.2.233     Document Type: Article

References (16)

1. Esmon CT, Fukudome K. Cellular regulation of the protein C pathway. Semin Cell Biol. 1995;6:259-268.
2. Dahlbäck B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci U S A. 1993;90:1004-1008.
3. Bertina RM, Koeleman BPC, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature. 1994;369:64-67.
4. Koster T, Rosendaal FR, de Ronde H, et al. Venous thrombosis due to poor response to activated protein C: Leiden thrombophilia study. Lancet. 1993;342:1503-1506.
5. Ridker PM, Hennekens CH, Lindpainter K, et al. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med. 1995;332:912-917.
6. Lane DA, Mannucci PM, Bauer KE, et al. Inherited thrombophilia: part 1.Thromb Haemost. 1996;76:651-662.
7. Van der Meer FJM, Koster T, Vandenbroucke JP, et al. The Leiden Thrombophilia Study (LETS). Thromb Haemost. 1997;78:631-635.
8. De Stefano V, Finazzi G, Mannucci PM. Inherited thrombophilia: pathogenesis, clinical syndromes, and management. Blood. 1996;87:3531-3544.
9. Kraus M, Noah M, Fickenscher K. The PCAT: a simple screening assay for assessing the functionality of the protein C anticoagulant pathway. Thromb Res. 1995;79:217-222.
10. Robert A, Eschwège V, Hameg H, et al. Anticoagulant response to Agkistrodon contortrix venom (ACV test): a new global test to screen for defects in the anticoagulant protein C pathway. Thromb Haemost. 1996;75:562-566.
11. Preda L, Simioni P, Legnani C, et al. A new global test for the evaluation of the protein C-protein S system. Blood Coagul Fibrinolysis. 1996;7:465-469.
12. Denson KWE, Haddon ME, Reed SV, et al. A more discriminating test for APC-resistance and a possible screening test to include protein C and protein S. Thromb Res. 1996;81:151-156.
13. Gable PS, Le DT, McGehee W, et al. A Protac-based screening test for activated protein C-resistant factor Va and other defects of the protein C anticoagulant pathway. Blood Coagul Fibrinolysis. 1997;8:327-335.
14. Dati F, Hafner G, Erbes H, et al. ProC Global: the first functional screening assay for the complete protein C pathway. Clin Chem. 1997;43:1719-1723.
15. Gable PS, Le DT, McGehee W, et al. Protac, a commercially available protein C activator from the venom of Agkistrodon contortrix contortrix, can activate factor V and factor VIII. Thromb Res. 1997;86:79-84.
16. Koster T, Blann AD, Briët E, et al. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet. 1995;345:152-155.